Skip to main content
. 2020 Mar 9;21(4):42–50. doi: 10.1002/acm2.12844

TABLE 3.

Comparison of the dosimetric parameters for nasopharyngeal tumor cases with RBE = 1.1 (equal to the treatment plan) and the variable RBE.

Case Tissue Dosimetric parameter PTV‐based opt. (cGy [RBE]) Robust opt. (cGy [RBE])
RBE = 1.1 Variable RBE ΔD99,ΔDmax[%] RBE = 1.1 Variable RBE ΔD99,ΔDmax[%]
CaseA CTV D 99 7220 7534/6987 4.4/−3.3 7223 7510/6980 4.0/−3.4
  D 98,worst   7040  
PTV D 95 7236    
Brainstem D max 3893 4947 15.2 4029 4675 9.0
Spinal cord D max 4199 5593 19.5 4199 4947 10.5
CaseB CTV D 99 7215 7531/6994 4.4/−3.1 7211 7585/7052 5.2/−2.2
  D 98,worst   7042  
PTV D 95 7232    
Brainstem D max 4505 5967 20.5 4573 5355 11.4
Spinal cord D max 2907 3893 13.8 2805 3417 8.6
CaseC CTV D 99 7198 7504/6960 4.3/−3.3 7221 7589/7028 5.2/−2.7
  D 98,worst   7039  
PTV D 95 7215    
Brainstem D max 4845 6001 16.2 4845 5797 13.3
Spinal cord D max 3553 4743 16.7 3281 4233 13.3
CaseD CTV D 99 7225 7531/7055 4.3/−2.4 7225 7463/6953 3.3/−3.8
  D 98,worst   7157  
PTV D 95 7191 16.7 13.3
Brainstem D max 3859 5015 16.2 3689 4675 13.8
Spinal cord D max 3077 4199 15.7 3043 3995 13.3

As for the dosimetric parameters for the CTV calculated with the variable RBE, the results of α/βx=3 and α/βx=12 are shown in the left and right sides in the same cell, respectively. Values of the dosimetric parameters are rounded to the nearest 0.1 cGy.

CTV, clinical target volume; PTV, planning target volume; RBE, relative biological effectiveness.